BioReference® honors laboratory professionals and pathologists during the 49th Annual Lab Week. We thank our dedicated lab professionals for making healthcare delivery possible. Read our blog bioreference.com/the-future-…
If you are at @ASH_Hematology meeting and expo this weekend in #SanDiego, be sure to stop by booth 142 to talk with us about our OnkoSuite™ of products including the OnkoSight® Advanced and OnkoClone™. #ASH23
We are excited to see you at booth 142 during the @ASH_hematology annual meeting and expo in San Diego, December 9-12! @GenPath will be showcasing its comprehensive OnkoSuite™ for hematology and oncology diagnostics. #ASH23
#LungCancer represents more than one eighth of all new cancer cases in the US and is the leading cause of cancer deaths worldwide. As we wrap up #NationalLungCancerAwarenessMonth, get informed of the facts, signs, and symptoms. bit.ly/47Tv7DE
Screening and diagnostic tests performed by clinical laboratories inform some of life’s most important health care decisions. Join @ACLAlabs to learn how you can help protect patient access to care by enacting #SALSA, and tell Congress to #StopLabCuts: bit.ly/3Sg5Xr5
Happy #LabWeek 2023! 🔬 This week, we celebrate the laboratory professionals who protect our future by skillfully adapting to meet today’s evolving patient care needs and public health challenges with resilience, innovation, and expertise. bit.ly/3UZZhQI
Did you know that 70% of medical decisions depend on laboratory test results (According to the @CDCgov) – making basic access to laboratory testing crucial for all Americans. Take a moment to join the @ACLAlabs to support #SALSA and #StopLabCuts ➡️ bit.ly/3Sg5Xr5
#DYK Cases of #STIs have increased substantially in recent years. Fortunately, clinical laboratory tests can help inform patient care and navigate necessary treatment. This #STIAwarenessMonth, @ACLAlabs highlights the value of recommended screening. bit.ly/3mEq5cj
Our CIO, Merve Oskus, will be speaking at #HIMSS23 about what organizations can do to manage security risks, modernize security systems, and minimize the potential for breaches without compromising patient care experiences. Learn more ➡️ bit.ly/3KFaC3z
We now offer OVA1Plus® to detect #ovariancancer risk in women diagnosed with a pelvic mass. OVA1plus combines two FDA-cleared blood tests, OVA1® and OVERA®, to detect risk of ovarian malignancy in women with adnexal masses prior to surgery. bit.ly/3g7KQJF
New #PAMA cuts could undermine laboratory infrastructure essential for day-to-day care and responding to public health emergencies, while also limiting innovation of new screening and diagnostic tests. Tell Congress to #StopLabCuts with @ACLAlabs here: bit.ly/3Sg5Xr5
It’s time for Congress to pass The Saving Access to Laboratory Services Act to further protect patient access to vital lab tests that can diagnose diabetes, heart disease, and other chronic conditions. Tell Congress to #StopLabCuts here➡️ bit.ly/3Sg5Xr5 @ACLAlabs
Did you know at BioReference, 56% of executive leadership and 60% of front line manager positions are held by women? Today and always, we’re committed to fostering an inclusive and diverse workplace where all can thrive. Learn more: bit.ly/3Cz4Qhy #WomensEqualityDay
Reduce healthcare-related stress by using Scarlet® for blood draws, urine collections, and more. @Scarlet_Health meets you where you are so you can save a trip out and get your blood drawn where you are most comfortable. Get started: bit.ly/3ibb3Em
You may be familiar with the immediate effects of a poor night’s sleep like drowsiness, but according to the CDC, persistent #sleepdeprivation can contribute to the development of chronic conditions like #heartdisease and #type2diabetes. Learn more here: bit.ly/3oBl81q
Today is #WorldLungCancerDay – an opportunity to raise awareness about risk factors, screening, and treatment options for this disease. Learn more about #lungcancer with @GenPath, a division of BioReference®: bit.ly/2NYoxo8
#ICYMI Chief Digital Officer & Head of @Scarlet_Health Richard Schwabacher discussed #hybridcare with other digital healthcare leaders at the @TeladocHealth forum yesterday in Boston.
#LIVE @TeladocHealth Forum: @RCS2130 discusses how #ScarletHealth improves healthcare access and helps contribute to better health outcomes that close critical gaps in patient care and complete the last medical mile. Here's an excerpt from the panel discussion:
Summer celebrations can introduce triggers for patients with food allergies. Specific IgE blood testing with BioReference can help identify sensitization to allergic triggers, providing the necessary information to develop a dietary management plan. bit.ly/3vG0Jd6
We’re excited to highlight our next MVP, Amanin. Known for going out of her way to share experience and advice, Amanin is recognized as a mentor within her Scarlet Health® team. Thank you, Amanin, for your rare dedication!
Today, our in-home lab specimen collection service, @Scarlet_Health announced a collaboration with @Teladoc Health, giving patients access to a seamless virtual healthcare experience – from lab test order to the physician visit. Read more, here: bioreference.com/teladoc-hea…
We are excited to announce the collaboration between Scarlet® and Teladoc. Now you can talk to a healthcare provider AND complete your lab test orders without leaving home. A complete healthcare experience is just a click away. Learn more: bit.ly/3NMNm3e





















